Abstract
The recent resurgence of interest in site specific delivery of radioisotopes, chemotherapeutic drugs and toxins for the diagnosis and treatment of cancer, and for the selective manipulation of the immune system, can be directly related to the need for improved diagnosis and the fact that for many cancers, for example lung, colon and gastric, the conventional treatments of surgery, radiotherapy and chemotherapy have reached a plateau in terms of the number of patients cured. To date, because of their specificity, the major emphasis has been on the use of antibodies as carriers and extensivein vitro, in vivo preclinical and clinical evaluation is underway. The aim of this article is to review recent progress, highlight avenues being explored to overcome limitations and to indicate new approaches that are evolving in antibody mediated targeting.
Similar content being viewed by others
References
Chabner BA, Fine RL, Allegra CJet al.Cancer 1984; 54: 2599–2608.
Rygaard J, Poulsen CO.Acta Path Microbiol Scand 1969; 77: 758–760.
Kohler G, Milstein C.Nature 1975; 256: 495–497.
Ford CHJ, Casson AG.Cancer Chemother Pharmacol 1986; 17: 197–208.
Houghton AN, Scheinberg DA.Sem Onc 1986; 13: 165–179.
Seaman WE, Wofsy D.Ann Rev Med 1988; 39: 231–241.
Larson SM. Cancer imaging with monoclonal antibodies. In : DeVitta VT Jr, Hellman S, Rosenberg SA, eds.Important Advances in Oncology (1986) : J.B. Lippincott Company, 1986; pp 233–249.
Cobb LM, Humm JL.Br J Cancer 1986; 54: 863–870.
Dykes PW, Bradwell AR, Chapman CEet al. Cancer Treat Rev 1987; 14: 87–106.
Ghose T, Blair AH, Uadia P.et al. Ann N Y Acad Sci 1985; 446: 213–227:
Neville DM Jr.Ann NY Acad Sci 1987; 155–164.
Vitetta ES, Fulton RJ, May RDet al. Science 1987; 238: 1098–1104.
Blakey DC, Thorpe PE.Antibody, Immunoconjugates, and Radiopharmaceuticals 1988; 1: 1–16.
Goding JW. London; Academic Press, 1986.
Mason DY, Gatter KC.J Clin Pathol 1987; 40: 1042–1054.
Polak JM.Int J Cancer 1988; Supplement 2 : 2–7.
Faure P, Chittal S, Woodman-Memeteau Fet al. Cancer 1988; 61: 1852–1861.
Ghose TI, Blair AH, Kulharni PN.Meths Enzymol 1983; 93: 280–333.
Cumber AJ, Forrester JA, Foxwell BMJet al. Meths Enzymol 1985; 112: 207–224.
FitzGerald DJ, Bjorn MJ, Ferris RJet al. Cancer Res 1987; 47: 1407–1410.
Embleton MJ.Br J Cancer 1987; 55: 227–231.
Levy R.J Clin Onc 1987; 5: 527–529.
Youle RJ.J Natnl Cancer Inst 1988; 80: 388–389.
Order SE. (Editor) NCI Monog 1987; 3 : 1–183.
2nd Conf Radioimmunodetection and Radioimmunotherapy of Cancer. New Yersey : 1988. (Entire Volume).
1st Internati Conf Monoclonal Antibody Immunoconjugates for Cancer. San Diego, 1987. (Entire Volume).
2nd Internati Conf Monoclonal Antibody Immunoconjugates for Cancer. San Diego, 1987. (Entire Volume).
3nd Internatl Conf Monoclonal Antibody Immunoconjugates for Cancer. San Diego, 1988. (Entire Volume).
Int J Cancer 1988; Supplement 2. (Entire Volume).
Schreiber H, Ward PL, Rowley DAet al. Ann Rev Imunol 1988; 6: 465–483.
Shively JE, Beatty JD. CRCCrit Rev Oncology Hae 1985; 2: 355–397.
Herlyn M, Koprowski H.Ann Rev Imunol 1988; 6: 283–308.
Sell S.Cancer markers: Past and present and future. In : Reisfeld RA, Sell S, eds. New York : Alan R. Liss, Inc., 1985; pp 3–21.
Endo N, Kato Y, Takeda Yet al. Cancer Res 1987; 47: 1076–1080.
Fand I, Sharkey RM, Primus FJet al. Cancer Res 1987; 47: 2177–2183.
Andrew SM, Perkins AC, Pimm MV, Baldwin RW.Eur J Nucl Med 1988; 13: 598–604.
Carrasquillo JA, Bunn PA Jr, Keenan AMet al. N Eng! J Med 1986; 315: 673–680.
Carrasquillo JA, Mulshine JL, Bunn PA Jret al. J Nucl Med 1987; 28: 281–287.
Kalofonos HP, Sivolapenko GB, Courtenay-Luck NSet al. Cancer Res 1988; 48: 1977–1984.
Riva P, Moscatelli G, Paganelli Get al. Int J Cancer 1988; Supplement 2 : 114–120.
Saleh MN, Miller DM, Peterson Let al. J Clin Oncol 1988; 6: 1059–1065.
Zimmer AM, Kazikiewicz JM, Rosen ST, Spies SM.Cancer Res 1987; 47: 1691–1694.
Siccardi AG, Buraggi GL, Callegaro Let al. Cancer Res 1986; 46: 4817–4822.
Koizumi M, Endo K, Kunimatsu Met al. Cancer Res 1988; 48: 1189–1194.
Hayes DF, Zalutsky MR, Kaplan Wet al. Cancer Res 1986; 46: 3157–3163.
Sharkey RM, Pykett MJ, Siegel JAet al. Cancer Res 1987; 47: 5672–5677.
Chiou RK, Vessella RL, Limas Cet al. Cancer 1988; 61: 1766–1775.
Buchegger F, Vacca A, Carrelet al. Int J Cancer 1988; 41: 127–134.
Lee Y, Bullard DE, Humphrey PAet al. Cancer Res 1988; 48: 2904–2910.
Wessels EW, Rogus RD.Med Phys 1984; 11: 638–645.
Humm JL.J Nucl Med 1986; 27: 1490–1497.
Sharkey RM, Primus FJ, Shochat D, Goldenberg DM.Cancer Res 1988; 48: 1823–1828.
Anderson-Berg WT, Squire RA, Strand M.Cancer Res 1987; 47: 1905–1912.
Order SE, Klein JL, Leichner PK.et al. Int J Rad Onc Biol Phys 1986; 12: 277–281.
Kozak RW, Atcher RW, Gansow OAet al Proc Natl Acad Sci USA 1986; 83: 474–478.
Kurtzman SH, Russo A, Mitchell JBet al. J Natl Cancer Inst 1988; 80: 449–452.
Macklis RM, Kinsey BM, Kassis AIet al. Science 1988; 240: 1024–1026.
Sugiyama Y, Chen F-A, Takita H, Bankert RB.Cancer Res 1988; 48: 2768–2773.
Rosen ST, Zimmer AM, Goldman-Leikin Ret al. J Clin Onc 1987; 5: 562–573.
Lashford LS, Davies AG, Richardson RBet al. Cancer 1988; 61: 857–868.
Ford CHJ, Bartlett SE, Casson AGet al. NCI Monog 1987; 3: 107–116.
Rowland GF, Simmonds RG, Gore VAet al. Cancer Immunol Immunother 1986; 21: 183–187.
Casson AG, Ford CHJ, Marsden CHet al. NCI Monog 1987; 3:117–124.
Ford CHJ, Bartlett SE, Casson AGet al. Tumor Biol 1987; 8: 358.
Richardson VJ, Ford CHJ, Tsaltas G, Gallant ME.Eur J Cancer Clin Oncol 1989; 25: 633–640.
Dillman RO, Shawler DL, Johnson DEet al. Cancer Res 1986; 46: 4886–4891.
Smyth MJ, Pietersz GA, Classon BJet al. J Natl Cancer Inst 1986; 76: 503–540.
Yang HM, Reisfeld RA.Proc Natl Acad Sci USA 1988; 85: 1189–1193.
Tsukada Y, Kato Y, Umemoto Net al. J Natl Cancer Inst 1984; 73: 721–728.
Ohkawa K, Tsukada Y, Hibi Net al. Cancer Immunol Immunother 1986; 23: 81–86.
Garnett MC, Baldwin RW.Cancer Res 1986; 46: 2407–2412.
Shih LB, Sharkey RM, Primus FJ, Goldberg DM.Int J Cancer 1988; 41: 832–839.
Alberici GF, Pallardy M, Manil Let al. Int J Cancer 1988; 41: 309–314.
Smyth MJ, Pietersz GA, McKenzie IFC.Br J Cancer 1987; 55: 7–11.
Smyth MJ, Pietersz GA, McKenzie IFC.Cancer Res 1987; 47: 62–69.
Bagshawe KD.Br J Cancer 1987; 56: 531–532.
Searle F, Bier C, Buckley RGet al. Br J Cancer 1986; 53: 377–384.
Liu MA, Nussbaum SR, Eisen HN.Science 1987; 239: 395–398.
Borlinghaus KP, Fitzpatrick DA, Heindel NDet al. Cancer Res 1987; 47: 4071–4075.
Pimm MV, Clegg JA, Garnett MC, Baldwin RW.Int J Cancer 1988; 41: 886–891.
Ghose T, Norvell ST, Guclu Aet al. JNCI 1977; 58: 845–852.
Ballantyne KC, Perkins AC, Pimm MVet al. Int J Cancer 1988; Suppl 2 :103–108.
Takahashi T, Yamaguchi T, Kitamura Ket al. Cancer 1988; 61: 881–888.
FitzGerald DJP.Meths Enzymol 1981; 151: 139–145
Weltman JK, Fedroso P, Johnson S-Aet al. Cancer Res 1987; 47: 5552–5556.
Till M, May RD, Uhr JWet al. Cancer Res 1988; 48: 1119–1123.
Levin LV, Griffin TW. Guilds LRet al. Cancer Immunol Immunother 1987; 24: 202–206.
Braham K, Junqua S, Tursz Tet al. Cancer Res 1988; 48: 806–811.
Marsh JW Neville DM Jr.Ann NY Acad Sci 1987; 507: 165–171.
Roth JA, Ames RS, Fry Ket al. Cancer Res 1988; 48: 3496–3501.
Scott CF Jr, Goldmacher VS, Lambert JMet al. J Natl Cancer Res 1987; 79: 1163–1172.
Hara H, Seon BK.Proc Natl Acad Sci USA 1987; 84: 3390–3394.
Griffin TW, Richardson C, Houston LLet al. Cancer Res 1987; 47: 4266–4270.
Byers VS, Pimm MV, Scannon PJet al. Cancer Res 1987; 47: 5042–5046.
Slater JE, Boltansky H, Kaliner M.J Immunol 1988; 140: 807–811.
Uckun FM, Myers DE, Ledbetter JAet al. J Immunol 1988; 140: 2103–2111.
Brown RM, Krolick KA.J Immunol 1988; 140: 893–898.
Ghetie M-A, May RD, Till Met al. Cancer Res 1988; 48: 2610–2617.
Preijers FWMB, Tax WJM, Wessels JMCet al. Scand J Immunol 1988; 27: 533–540.
Gregg EO, Bridges SH, Youle RJet al. J Immunol 1987; 138: 4502–4508.
Fulton RJ, Tucker TF, Vitetta ES, Uhr JW.Cancer Res 1988; 48: 2618–2625.
Blakey DC, Watson GJ, Knowles PP, Thorpe PE.Cancer Res 1987; 47: 947–952.
Fulton RJ, Uhr JW, Vitetta ES.Cancer Res 1988; 48: 2626–2631.
Byers VS, Pimm MV, Pawluczyk IZAet al. Cancer Res 1987; 47: 5277–5283.
Thorpe PE, Wallace PM, Knowles PPet al. Cancer Res 1987; 47: 5924–5931.
Thiesen H-J, Juhl H, Arndt R.Cancer Res 1987; 47: 419–423.
Greenfield L, Johnson VG, Youle RJ.Science 1987; 238: 536–539.
Godal A, Fodstad O, Pihl A.Cancer Res 1987; 47: 6243–6247.
Ghetie M-A, Moraru I, Margineanu M, Ghetie V.Molec Immunol 1988; 25: 473–477.
Mota G, Margineanu M, Nicolae Met al. Immunol Lett 1988; 18: 67–72.
Fodstad O, Kvalheim G, Pihl Aet al. J Natl Cancer Inst 1988: 80 : 439–443.
Laurent G, Pris J, Farcet J-Pet al. Blood 1986; 67: 1680–1687.
Spitler LE, del Rio M, Khentigan Aet al. Cancer Res 1987; 47: 1717–1723.
Spitler LE. In : Frankel AE ed.Immunotoxins. Boston : Nijhoff. In press.
Kernan NA, Byers V, Scannon PJet al. JAMA 1988; 259: 3154–3157.
Gorin NC, Douay L, Laporte JPet al. Cancer Treat Rep 1985; 69: 953–959.
Coombes RC, Buckman R, Forrester JAet al. Cancer Res 1986; 46: 4217–4200.
Winter JN, Marder RJ, Mankad B, Epstein AL.Cancer 1988; 61: 1082–1090.
Glennie MJ, McBride HM, Stirpe Fet al. J Exp Med 1987; 166: 43–62.
Poynton CH, Shaw PJ, Barrett AJ. Lancet 1986; i: 162.
Sugita K, Majdic O, Stockinger Het al. Int J Cancer 1986; 37: 351–357.
Herve P.J Natl Cancer Inst 1986; 76: 1311–1316.
Haleem A, Kurtzberg J, Olsen GAet al. Cancer Res 1987; 47: 4608–4612.
Bregni M, De Fabritiis P, Raso Vet al. Cancer Res 1986; 46: 1208–1213.
Kemshead JT, Heath L, Gibson FMet al. Br J Cancer 1986; 54: 771–779.
Gee AP, Boyle MDP.J Natl Cancer Inst 1988; 80: 154–159.
Larson SM.Nucl Med Biol 1986; 13: 393–399.
Sutherland R, Buchegger F, Schreyer Met al. Cancer Res 1987; 47: 1627–1633.
Kwok CS, Cole SE, Liao S-K.Cancer Res 1988; 48: 1856–1863.
Brown BA, Comeau RD, Jones PLet al. Cancer Res 1987; 47: 1149–1154.
Harwood PJ, Pedley PB, Boden J, Rogers GT.Tumor Biol 1987; 8: 19–25.
Vacca A, Buchegger F, Carrel S, Mach J-P.Cancer 1988; 61: 58–67.
Hnatowich DJ, Gionet M, Rusckowskiet al. Cancer Res 1987; 47: 6111–6117.
Hnatowich DJ, Griffin TW, Kosciuczyk C.J Nucl Med 1985; 26: 849–858.
Rogers GR, Pedley B, Boden Jet al. Cancer Immunol Immunother 1986; 23: 107–112.
Hagan PL, Halpern SE, Dillman ROet al. J Nucl Med 1986; 27: 422–427.
Philben VJ, Jakowatz Jg, Beatty BGet al. Cancer 1986; 57: 571–576.
Sharkey RM, Primus FJ, Goldenberg DM.Int J Cancer 1987; 39: 611–617.
Kirkwood JM, Neumann RD, Zoghbi SSet al. J Clin Oncol 1987; 5: 1247–1255.
Paganelli G, Riva P, Deleide Get al. Int J Cancer 1988; Supplement 2 : 121–125.
Foxwell BMJ, Band HA, Long Jet al. Br J Cancer 1988; 57: 489–493.
Sharkey RM, Mabus J, Goldenberg DM.Cancer Res 1988; 48: 2005–2009.
Matzku S, Tilgen W, Kalthoff Het al. Int J Cancer 1988; Supplement 2 : 11–14.
Ward BG, Wallace K.Cancer Res 1987; 47 ; 4714–4718.
Ward BG, Mather SJ, Hawkins LRet al. Cancer Res 1987; 47: 4719–4723.
Rowlinson G, Snook D, Busza A, Epenetos AA.Cancer Res 1988; In press :
Ahlstrom H, Carlsson L, Hedin A, Lorelius LE.Acta Oncolog 1987; 26, Fasc. 6: 453–458.
Colcher D, Esteban JM, Carrasquillo JAet al. Cancer Res 1987; 47: 1185–1189.
Esteban JM, Colcher D, Sugarbaker Pet al. Int J Cancer 1987; 39: 50–59.
Smyth MJ, Pietersz GA, McKenzie IFC.JNCI 1987; 79: 1367–1373.
Greiner JW.Cancer Invest 1986; 4: 239–256.
Macdonald F, Crowson MC, Allum WHet al. Cancer Immunol Immunother 1986; 23: 119–124.
Byers VS, Pawlucyzk I, Berry Net al. J Immunol 1988; 140: 4050–4055.
Welt S, Mattes MJ, Grando Ret al. Proc Nat lAcad Sci USA 1987; 84: 4200–4204.
Embleton MJ, Habib NA, Garnett MC, Wood C.Int J Cancer 1986; 38: 821–827.
Greiner JW, Guadagni F, Noguchi Pet al. Science 1987; 235: 895–898.
Rosenblum MG, Lamki LM, Murray JL.et al. J Natl Cancer Inst 1988; 80: 160–165.
Weiner LM, Moldofsky PJ, Gatenby RAet al. Cancer Res 1988; 48: 2568–2573.
Weil-Hillman G, Uckun FM, Manske Jm, Vallera DA.Cancer Res 1987; 47: 579–585.
Wang BS, Lumanglas AL, Silvaet al. Cell Immunol 1987; 106: 12–21.
Goldenberg DM, Goldenberg H, Higginbotham-Ford Eet al. J Clin Onc 1987; 5: 1827–1835.
Matzku S, Bruggen J, Brocker E-B, Sorg C.Cancer Immunol Immunother 1987; 24: 151–157.
Matzku S, Brocker E-B, Bruggenet al. Cancer Res 1986; 46: 3848–3854.
Torre GD, Canevari S, Orlandi R, Colnaghi MI.Br J Cancer 1987; 55: 357–359.
Aboud-Pirak E, Sergent T, Otte-Slachmuylder Cet al. Cancer Res 1988; 48: 3188–3196.
Uadia P, Blair AH, Ghose T, Femme S.J Natl Cancer Inst 1985; 74: 29–35.
Shen W-C, Ballou B, Ryser HJ-P, Hakala TR.Cancer Res 1986; 46: 3912–3916.
Endo N, Takeda Y, Umemoto Net al. Cancer Res 1988; 48: 3330–3335.
Meeker TC, Lowder J, Maloney DGet al. Blood 1985; 65: 1349–1363.
Traub UC, DeJager RL, Primus FJet al. Cancer Res 1988; 48: 4002–4006.
Cobb LM, Humphreys JA, Harrison A.Br J Cancer 1987; 55: 53–55.
Kjeldsen TB, Rasmussen BB, Rose C, ZeuthenJ. Cancer Res 1988; 48: 3208–3214.
Saito H, Uchiyama K, Nakamura Iet al. J Natl Cancer Inst 1988; 80: 728–734.
Ramachandra RN, Berczi I, Sehon AH.Immunol Lett 1988; 18: 93–98.
Borrebaeck CAK, Danielsson L, Moller SA.Froc Natl Acad Sci 1988; 85: 3995–3999.
Cobbold SP, Waldmann H.Nature 1984; 308: 460–462.
Milstein C, Cuello AC.Immunol Today 1984; 5: 299–304.
Brennan M, Davison PF, Paulus H.Science 1985; 229: 81–83.
Hammerling U, Aoki T, De Harven Eet al. J Exp Med 1968; 128: 1461–1469.
Nisonoff A, Palmer JL.Science 1964; 143: 376–379.
Ghetie V, Mota G.J Immunol 1980; 17: 395–401.
Lansdorp PM, Aalberse RC, Bos R.J Eur J Immunol 1986; 16: 679–683.
Paulus H.Behring Inst Mitt 1985; 78: 118–132.
Milstein C, Cuello AC.Nature 1983; 305: 537–540.
Leong MML, Milstein C, Pannell R.J Histochem Cytochem 1986; 34: 1645–1650.
Karawajew L, Behrsing O, Kaiser G, Micheel B.J Immunol Meths 1988; 111: 95–99.
Corvalan JRF, Smith W.Cancer Immunol Immunother 1987; 24: 127–132.
Webb KS, Ware JL, Parks SFet al. Cancer Treat Rep 1985; 69: 663–672.
Tiebout RF, van Boxtel-Oosterhof F, Strieker EAM, Zeijlemaker WT.J Immunol 1987; 139: 3402–3405.
Corvalan JRF, Smith W, Gore VA, Brandon DR.Cancer Immunol Immunother 1987; 24: 133–137.
Corvalan JRF, Smith W, Gore VACancer Immunol Immunother 1987; 24: 138–143.
Reddy VS, Ford CHJ. 9th Europ Immunol Meeting, Rome 1988.
Bernards R.Trends in Genetics 1987; 3: 298–301.
Lanzavecchia A. In : Intl Symp Monoclonals and DNA Probes in Diagnostic and Preventive Medicine. Florence, Italy : 1986; p. 53. Abstract.
Staerz UD, Kanagawa O, Bevan MJ.Nature 1985; 314: 628–631.
Kranz DM, Tonegawa S, Eisen HN.Proc Natl Acad Sci 1984; 81: 7922–7926.
Barr IG, MacDonld HR, Buchegger F, von Fliedner V.Int J Cancer 1987; 40: 423–429.
Staerz UD, Bevan MJ.Proc Natl Acad Sci 1986; 83: 1453–1457.
Staerz UD, Bevan MJ.Immunol Today 1986; 7: 241–245.
Taussig MJ.Immunol 1988; Supplement 1 : 7–16.
Williams AF, Barclay AN.Ann Rev Imunol 1988; 6: 381–405.
Morrison SL.Science 1985; 329: 1202–1207.
Verhoeyen M, Riechmann L.BioEssays 1988; 8: 74–78.
Neuberger MS, Williams G, Fox RO.Nature 1984; 312: 604–608.
Bruggemann M, Williams G, Bindon CIet al. J Exp Med 1987; 166: 1351–1361.
Shaw DR, Khazaeli MB, Sun Lket al. J Immunol 1987; 138: 4534–4538.
Sun LK, Curtis P, Rakowicz-Szulczynskaet al. Proc Natl Acad Sci 1987; 84: 214–218.
Sahagan BG, Dorai H, Saltzgaber-Muller Jet al. J Immunol 1986; 137: 1066–1074.
Brown Ba, Davis GL, Saltzgaber-Muller Jet al. Cancer Res 1987; 47: 3577–3583.
Liu AY, Robinson R, Hellstrom KEet al. Proc Natl Acad Sci 1987; 84: 3439–3443.
Liu AY, Robinson R, Murray, ED Jret al. J Immunol 1987; 139: 3521–3526.
Jones PT, Dear PH, Foote Jet al. Nature 1986; 321: 522–525.
Riechmann L, Clark M, Waldmann H, Winter G.Nature 1988; 332: 323–327.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Ford, C.H.J., Richardson, V.J. & Reddy, V.S. Antibody mediated targeting of radioisotopes, drugs and toxins in diagnosis and treatment. Indian J Pediatr 57, 29–46 (1990). https://doi.org/10.1007/BF02722127
Issue Date:
DOI: https://doi.org/10.1007/BF02722127